✨ Unlock Data Exports And Disclosure Access.Start Your 30-Day Free Trial Today →

Cipla Ltd

Common Name
Cipla
Country
India
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
30,313
Ticker
CIPLA
Exchange
National Stock Exchange of India
Description
Cipla Ltd. is an Indian pharmaceutical company that develops, manufactures, and markets a broad range of medicines and healthcare products for patients and healthcare providers worldwide. Its current ...

Cipla's Financial Statements Preview

Below are the financial statements of Cipla, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in billions of INR
2025
2024
Income
Revenue from operations
Revenue from sale of products
271.45a
254.47a
Other operating revenue
4.02a
3.27a
Total revenue from operations
275.48a
257.74a
Other income
8.62a
7.47a
Total income
284.09a
265.21a
Expenses
Cost of materials consumed
-54.1a
-52.21a
Purchases of stock-in-trade
-38.51a
-35.36a
Changes in inventories of finished goods, work-in-progress and stock-in-trade
-3.32a
-0.63a
Employee benefits expense
-48.33a
-43.1a
Finance costs
-0.62a
-0.9a
Depreciation, impairment and amortisation expense
-11.07a
-10.51a
Other expenses
-66.58a
-63.53a
Total expenses
-215.89a
-206.24a
Profit before exceptional item, tax and share of associates
68.21a
58.97a
Exceptional item
0a
-1.95a
Profit before tax and share of associates
68.21a
57.02a
Tax expense/credit (net)
Current tax
-17.08a
-16.97a
Deferred tax
-1.79a
-1.5a
Total tax expense
-15.3a
-15.47a
Net profit after tax before share of profit/(loss) from associates
52.91a
41.55a
Share of profit/(loss) from associates
-0.22a
-0.02a
Net profit for the year
52.69a
41.54a
Other comprehensive income/(loss)
Items that will not be reclassified to profit or loss
-0.66a
-0.89a
Income tax on item that will not be reclassified to profit or loss
0.1a
0.28a
Items that will be reclassified to profit or loss
2.76a
-0.59a
Income tax on item that will be reclassified to profit or loss
-0.01a
-0.01a
Other comprehensive income/(loss) for the year
2.19a
-1.21a
Total comprehensive income for the year
54.88a
40.33a
Profit for the year attributable to
Owners
52.73a
41.22a
Non-controlling interest
-0.03a
0.32a
Other comprehensive income/(loss) attributable to
Owners
2.17a
-1.24a
Non-controlling interest
0.02a
0.03a
Total comprehensive income attributable to
Owners
54.89a
39.98a
Non-controlling interest
-0.02a
0.35a
Usage Policy

You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"

Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.

Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Cipla’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.

a. Cipla's Annual Report 2025
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?